Sarepta Therapeutics (SRPT)

• Market cap: $6.97B
• 1 day: -1.47%
• 5 days: -2.06%
• 1 month: -30.32%
• 3 months: -40.90%
• 6 months: -42.34%
• Year to date: -42.13%
• 1 year: -44.86%
• 5 years: -23.96%
• 10 years: 429.18%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

38% more funds holding in top 10

Funds holding in top 10: 8 [Q3] → 11 (+3) [Q4]

19% more first-time investments, than exits

New positions opened: 74 | Existing positions closed: 62

15% more call options, than puts

Call options by funds: $211M | Put options by funds: $184M

0.68% more ownership

Funds ownership: 92.34% [Q3] → 93.02% (+0.68%) [Q4]

1% more funds holding

Funds holding: 452 [Q3] → 455 (+3) [Q4]

1% more repeat investments, than reductions

Existing positions increased: 156 | Existing positions reduced: 155

3% less capital invested

Capital invested by funds: $11B [Q3] → $10.7B (-$301M) [Q4]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $75 4% upside
• Avg. target: $122 70% upside
• High target: $202 181% upside

7 analyst ratings

• positive: 3 43%
• neutral: 2 29%
• negative: 2 29%

Scotiabank Louise Chen 34% 1-year accuracy 48 / 140 met price target	11% upside $80	Sector Perform Maintained	20 Mar 2025
Cantor Fitzgerald Kristen Kluska 32% 1-year accuracy 35 / 109 met price target	127% upside $163	Overweight Reiterated	19 Mar 2025
HC Wainwright & Co. Mitchell Kapoor 33% 1-year accuracy 60 / 182 met price target	4% upside $75	Sell Reiterated	19 Mar 2025
Deutsche Bank David Hoang 41% 1-year accuracy 7 / 17 met price target	38% upside $99	Hold Maintained	19 Mar 2025
Needham Gil Blum 11% 1-year accuracy 18 / 162 met price target	181% upside $202	Buy Reiterated	18 Mar 2025